Skip to main content
Premium Trial:

Request an Annual Quote

Sanford Health to Develop Self-Phenotyping System With Australian Startup

CHICAGO (GenomeWeb) – Genome.One, an Australian startup offering clinical whole-genome sequencing services to help diagnose rare genetic conditions, will work with Sanford Health to develop a platform to incorporate patient-generated health data into WGS data, the companies announced yesterday.

The two organizations are aiming to combine data provided by Sanford patients with information in electronic health records and genetic and research knowledge bases. This, according to Sanford Health, offers promise for diagnosis and treatment of rare diseases.

"The self-phenotyping program will allow us to further integrate patient-generated and clinical data with genetic information. The integration of data from many sources will help Sanford’s primary care physicians provide the best care to our patients and will be critical in realizing the benefits of genome-based personalized healthcare,” Cornelius Boerkoel, executive director of the Sanford Imagenetics program, said in a statement.

Sanford Imagenetics, the genomics program at the Sioux Falls, South Dakota-based health system, was founded in 2014 with a $125 million gift from philanthropist Denny Sanford to integrate genetic testing into primary care. Among its activities, Imaginetics collects turns questionnaires on patient experiences into machine-readable data to inform clinical and research decisions.

Genome.One is a year-old spinoff from the Garvan Institute of Medical Research in Sydney.